Switch theme
Sign up to access all valuation multiples
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
2002
188
LTM Revenue $61.3M
LTM EBITDA -$46.2M
$174M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Codexis has a last 12-month revenue of $61.3M and a last 12-month EBITDA of -$46.2M.
In the most recent fiscal year, Codexis achieved revenue of $59.3M and an EBITDA of -$53.4M.
Codexis expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Codexis valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $70.1M | $59.3M | XXX | XXX | XXX |
| Gross Profit | $101M | $57.3M | XXX | XXX | XXX |
| Gross Margin | 143% | 97% | XXX | XXX | XXX |
| EBITDA | -$44.9M | -$53.4M | XXX | XXX | XXX |
| EBITDA Margin | -64% | -90% | XXX | XXX | XXX |
| Net Profit | -$33.6M | -$76.2M | XXX | XXX | XXX |
| Net Margin | -48% | -128% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 28, 2025, Codexis's stock price is $2.
Codexis has current market cap of $187M, and EV of $174M.
See Codexis trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $174M | $187M | XXX | XXX | XXX | XXX | $-0.84 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 28, 2025, Codexis has market cap of $187M and EV of $174M.
Codexis's trades at 2.8x LTM EV/Revenue multiple, and -3.8x LTM EBITDA.
Analysts estimate Codexis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Codexis and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $174M | XXX | XXX | XXX |
| EV/Revenue | 2.9x | XXX | XXX | XXX |
| EV/EBITDA | -3.3x | XXX | XXX | XXX |
| P/E | -2.9x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -3.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCodexis's NTM/LTM revenue growth is 15%
Codexis's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.5M for the same period.
Over next 12 months, Codexis's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Codexis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Codexis and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -15% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -90% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -75% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.5M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 78% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 171% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Corbion | XXX | XXX | XXX | XXX | XXX | XXX |
| Gujarat State Fertilizers & Chemicals | XXX | XXX | XXX | XXX | XXX | XXX |
| Industries Qatar | XXX | XXX | XXX | XXX | XXX | XXX |
| K+S | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Codexis acquired XXX companies to date.
Last acquisition by Codexis was XXXXXXXX, XXXXX XXXXX XXXXXX . Codexis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Codexis founded? | Codexis was founded in 2002. |
| Where is Codexis headquartered? | Codexis is headquartered in United States of America. |
| How many employees does Codexis have? | As of today, Codexis has 188 employees. |
| Who is the CEO of Codexis? | Codexis's CEO is Dr. Stephen Dilly, M.B.B.S.,PhD. |
| Is Codexis publicy listed? | Yes, Codexis is a public company listed on NAS. |
| What is the stock symbol of Codexis? | Codexis trades under CDXS ticker. |
| When did Codexis go public? | Codexis went public in 2010. |
| Who are competitors of Codexis? | Similar companies to Codexis include e.g. Fertiglobe, Corbion, Gujarat State Fertilizers & Chemicals, Industries Qatar. |
| What is the current market cap of Codexis? | Codexis's current market cap is $187M |
| What is the current revenue of Codexis? | Codexis's last 12-month revenue is $61.3M. |
| What is the current EBITDA of Codexis? | Codexis's last 12-month EBITDA is -$46.2M. |
| What is the current EV/Revenue multiple of Codexis? | Current revenue multiple of Codexis is 2.8x. |
| What is the current EV/EBITDA multiple of Codexis? | Current EBITDA multiple of Codexis is -3.8x. |
| What is the current revenue growth of Codexis? | Codexis revenue growth between 2023 and 2024 was -15%. |
| Is Codexis profitable? | Yes, Codexis is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
